HomeAI · summaries
Storia in 2 fonti
BMS launches dual immunotherapy for metastatic melanoma
BMS launches RELOPDUO, India's first LAG-3 dual immunotherapy for metastatic melanoma, enhancing cancer treatment options.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
thehindu.com
BMS launches dual immunotherapy for metastatic melanoma
BMS launches RELOPDUO, India's first LAG-3 dual immunotherapy for metastatic melanoma, enhancing cancer treatment options.
- ·
thehindubusinessline.com
Bristol Myers Squibb launches Relopduo, its fixed-dose combination for skin cancer, in India
Bristol Myers Squibb launches Relopduo in India, a groundbreaking fixed-dose combination for treating skin cancer.